Symbols / ACH Stock $3.30 -1.79% Accendra Health, Inc.

Healthcare • Medical Distribution • United States • NYQ
ACH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Distribution
CEO Mr. Edward A. Pesicka
Exch · Country NYQ · United States
Market Cap 252.25M
Enterprise Value 2.13B
Income -102.68M
Sales 2.76B
FCF (ttm) 671.68M
Book/sh -6.04
Cash/sh 3.69
Employees 6,500
Insider 10d —
IPO Mar 17, 1980
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 3.17
PEG 0.70
P/S 0.09
P/B -0.55
P/C —
EV/EBITDA 5.92
EV/Sales 0.77
Quick Ratio 0.40
Current Ratio 0.58
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -1.34
EPS next Y 1.04
EPS Growth —
Revenue Growth -73.70%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-19
ROA 2.57%
ROE -163.78%
ROIC —
Gross Margin 46.68%
Oper. Margin 2.94%
Profit Margin -39.85%
Shs Outstand 76.44M
Shs Float 56.11M
Insider Own 7.60%
Instit Own 94.14%
Short Float 11.09%
Short Ratio 8.14
Short Interest 6.86M
52W High 9.55
vs 52W High -65.45%
52W Low 1.84
vs 52W Low 79.35%
Beta 1.26
Impl. Vol. 1.38%
Rel Volume 0.52
Avg Volume 892.04K
Volume 460.90K
Target (mean) $3.25
Tgt Median $3.00
Tgt Low $2.25
Tgt High $5.00
# Analysts 5
Recom None
Prev Close $3.36
Price $3.30
Change -1.79%
About

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$3.25
Mean price target
2. Current target
$3.30
Latest analyst target
3. DCF / Fair value
$158.17
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.30
Low
$2.25
High
$5.00
Mean
$3.25

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-20 main Leerink Partners Market Perform → Market Perform $3
2026-01-09 main Citigroup Buy → Buy $4
2025-11-03 down UBS Buy → Neutral $4
2025-08-27 main JP Morgan Underweight → Underweight $6
2025-08-13 main UBS Buy → Buy $7
2025-08-12 main Baird Outperform → Outperform $7
2025-08-12 main Citigroup Buy → Buy $7
2025-08-12 main B of A Securities Underperform → Underperform $5
News
RSS: Latest ACH news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-09 GALLOWAY HEATH H. General Counsel — 61,437 $0.00 $0
2026-03-09 LEON JONATHAN A Chief Financial Officer — 85,067 $0.00 $0
2026-03-09 BERNOCCHI PERRY A Chief Operating Officer — 108,696 $0.00 $0
2025-11-19 LONG ANDREW G. Chief Executive Officer — 47,908 $0.00 $0
2025-08-14 COLISEUM CAPITAL MANAGEMENT, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 1,537,852 $5.15 $8,099,544
2025-05-15 BECK MARK A. Director — 28,914 $0.00 $0
2025-05-15 KLINE TERESA L. Director — 28,914 $0.00 $0
2025-05-15 JOHNSON-MILLS RITA Director — 28,914 $0.00 $0
2025-05-15 HENKEL ROBERT J Director — 28,914 $0.00 $0
2025-05-15 KLEMASH STEPHEN W. Director — 28,914 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2,762.03
+3.06%
2,680.11
+5.00%
2,552.57
-74.36%
9,955.48
Operating Revenue
2,762.03
+3.06%
2,680.11
+5.00%
2,552.57
-74.36%
9,955.48
Cost Of Revenue
1,472.73
+5.22%
1,399.73
+4.81%
1,335.55
-83.57%
8,129.12
Reconciled Cost Of Revenue
1,472.73
+5.22%
1,399.73
+4.81%
1,335.55
-83.57%
8,129.12
Gross Profit
1,289.30
+0.70%
1,280.38
+5.21%
1,217.02
-33.36%
1,826.35
Operating Expense
1,067.56
-1.37%
1,082.34
+8.06%
1,001.66
-35.36%
1,549.57
Selling General And Administration
1,067.56
-1.37%
1,082.34
+8.06%
1,001.66
-35.58%
1,554.82
Other Operating Expenses
—
13.32
+92.15%
6.93
+231.95%
-5.25
Total Expenses
2,540.29
+2.35%
2,482.08
+6.20%
2,337.21
-75.85%
9,678.69
Operating Income
221.74
+11.97%
198.04
-8.05%
215.36
-22.19%
276.78
Total Operating Income As Reported
27.46
+112.61%
-217.73
-263.42%
133.23
-6.77%
142.91
EBITDA
219.75
+635.49%
-41.04
-111.99%
342.40
-7.07%
368.45
Normalized EBITDA
432.32
+15.37%
374.73
-11.73%
424.54
-15.48%
502.32
Reconciled Depreciation
214.52
+18.34%
181.28
-13.83%
210.37
-8.00%
228.67
EBIT
5.23
+102.35%
-222.32
-268.38%
132.03
-5.54%
139.78
Total Unusual Items
-212.57
+48.87%
-415.77
-406.21%
-82.13
+38.65%
-133.87
Total Unusual Items Excluding Goodwill
-212.57
+48.87%
-415.77
-406.21%
-82.13
+38.65%
-133.87
Special Income Charges
-212.57
+48.87%
-415.77
-406.21%
-82.13
+38.65%
-133.87
Other Special Charges
—
1.10
+131.30%
-3.52
—
Impairment Of Capital Assets
0.00
-100.00%
307.11
0.00
0.00
Restructuring And Mergern Acquisition
212.57
+95.64%
108.65
+32.29%
82.13
-38.65%
133.87
Net Income
-1,100.64
-203.47%
-362.69
-778.15%
-41.30
-284.47%
22.39
Pretax Income
-101.95
+69.09%
-329.88
-2261.05%
15.27
+40.16%
10.89
Net Non Operating Interest Income Expense
-107.18
+0.36%
-107.57
+7.88%
-116.77
+9.40%
-128.89
Interest Expense Non Operating
107.18
-0.36%
107.57
-7.88%
116.77
-9.40%
128.89
Net Interest Income
-107.18
+0.36%
-107.57
+7.88%
-116.77
+9.40%
-128.89
Interest Expense
107.18
-0.36%
107.57
-7.88%
116.77
-9.40%
128.89
Other Income Expense
-216.51
+48.49%
-420.36
-404.45%
-83.33
+39.18%
-137.00
Other Non Operating Income Expenses
-3.94
+14.10%
-4.59
-283.38%
-1.20
+61.77%
-3.13
Tax Provision
0.73
-96.50%
20.85
+227.83%
6.36
+155.31%
-11.50
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-44.64
+48.87%
-87.31
-406.21%
-17.25
+38.65%
-28.11
Net Income Including Noncontrolling Interests
-1,100.64
-203.47%
-362.69
-778.15%
-41.30
-284.47%
22.39
Net Income From Continuing Operation Net Minority Interest
-102.68
+70.72%
-350.74
-4038.63%
8.90
-60.23%
22.39
Net Income From Continuing And Discontinued Operation
-1,100.64
-203.47%
-362.69
-778.15%
-41.30
-284.47%
22.39
Net Income Continuous Operations
-102.68
+70.72%
-350.74
-4038.63%
8.90
-60.23%
22.39
Net Income Discontinuous Operations
-997.96
-8250.43%
-11.95
+76.20%
-50.21
0.00
Normalized Income
65.25
+392.85%
-22.28
-130.19%
73.79
-42.42%
128.15
Net Income Common Stockholders
-1,100.64
-203.47%
-362.69
-778.15%
-41.30
-284.47%
22.39
Diluted EPS
—
-4.73
-775.93%
-0.54
-286.21%
0.29
Basic EPS
—
-4.73
-775.93%
-0.54
-280.00%
0.30
Basic Average Shares
—
76.74
+1.26%
75.78
+1.73%
74.50
Diluted Average Shares
—
76.74
+1.26%
75.78
-0.57%
76.22
Diluted NI Availto Com Stockholders
-1,100.64
-203.47%
-362.69
-778.15%
-41.30
-284.47%
22.39
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
2,451.76
-47.34%
4,656.16
-8.58%
5,093.32
-5.44%
5,386.28
Current Assets
547.87
-72.89%
2,021.02
-3.89%
2,102.79
-8.38%
2,295.18
Cash Cash Equivalents And Short Term Investments
281.99
+922.74%
27.57
-88.66%
243.04
+249.86%
69.47
Cash And Cash Equivalents
281.99
+922.74%
27.57
-88.66%
243.04
+249.86%
69.47
Receivables
95.91
-56.06%
218.27
-63.52%
598.26
-21.64%
763.50
Accounts Receivable
95.91
-56.06%
218.27
-63.52%
598.26
-21.64%
763.50
Gross Accounts Receivable
103.58
-54.10%
225.67
-62.77%
606.16
-21.54%
772.60
Allowance For Doubtful Accounts Receivable
-7.68
-3.71%
-7.40
+6.29%
-7.90
+13.19%
-9.10
Inventory
74.44
+10.14%
67.58
-93.91%
1,110.61
-16.72%
1,333.59
Raw Materials
—
77.92
+2.92%
75.71
—
Work In Process
—
59.12
-3.92%
61.53
—
Finished Goods
74.44
+10.14%
67.58
-93.57%
1,051.55
-21.15%
1,333.59
Assets Held For Sale Current
0.00
-100.00%
1,625.35
—
—
Other Current Assets
95.54
+16.17%
82.24
-45.50%
150.89
+17.30%
128.64
Total Non Current Assets
1,903.89
-27.75%
2,635.14
-11.88%
2,990.53
-3.25%
3,091.10
Net PPE
365.26
-2.91%
376.21
-55.24%
840.50
-2.15%
858.93
Gross PPE
572.86
+2.30%
559.96
-59.63%
1,386.90
+5.93%
1,309.22
Accumulated Depreciation
-207.59
-12.98%
-183.75
+66.37%
-546.40
-21.34%
-450.29
Properties
0.00
0.00
0.00
0.00
Land And Improvements
—
9.38
-59.16%
22.96
+0.48%
22.85
Buildings And Improvements
13.52
-43.55%
23.95
-88.14%
201.94
+2.39%
197.23
Machinery Furniture Equipment
—
472.59
-4.05%
492.55
+4.78%
470.07
Construction In Progress
—
32.19
+200.01%
10.73
-25.50%
14.40
Other Properties
559.33
+4.35%
536.00
-18.63%
658.73
+8.94%
604.67
Goodwill And Other Intangible Assets
1,364.61
-5.12%
1,438.20
-28.11%
2,000.68
-3.89%
2,081.75
Goodwill
1,228.14
+0.00%
1,228.14
-25.06%
1,638.85
+0.13%
1,636.70
Other Intangible Assets
136.47
-35.03%
210.06
-41.95%
361.83
-18.70%
445.04
Other Non Current Assets
174.03
-78.80%
820.73
+449.55%
149.35
-0.71%
150.42
Total Liabilities Net Minority Interest
2,912.74
-28.43%
4,069.79
-2.38%
4,169.16
-6.11%
4,440.68
Current Liabilities
947.08
-48.86%
1,852.05
-2.11%
1,891.88
+20.77%
1,566.47
Payables And Accrued Expenses
432.99
-0.14%
433.61
-66.34%
1,288.28
+3.83%
1,240.71
Payables
363.56
+1.01%
359.93
-69.29%
1,171.88
+2.13%
1,147.41
Accounts Payable
363.56
+1.01%
359.93
-69.29%
1,171.88
+2.13%
1,147.41
Current Accrued Expenses
69.43
-5.77%
73.68
-36.70%
116.40
+24.76%
93.30
Current Debt And Capital Lease Obligation
250.00
+483.21%
42.87
-79.28%
206.90
+1055.50%
17.91
Current Debt
250.00
+483.21%
42.87
-79.28%
206.90
+1055.50%
17.91
Other Current Borrowings
—
40.00
—
—
Current Capital Lease Obligation
—
5.20
—
—
Other Current Liabilities
264.08
-80.80%
1,375.58
+246.76%
396.70
+28.86%
307.85
Total Non Current Liabilities Net Minority Interest
1,965.66
-11.37%
2,217.74
-2.61%
2,277.27
-20.77%
2,874.21
Liabilities Heldfor Sale Non Current
0.00
-100.00%
237.89
—
—
Long Term Debt And Capital Lease Obligation
1,870.19
-0.94%
1,887.86
-10.66%
2,113.03
-21.69%
2,698.44
Long Term Debt
1,799.88
+0.08%
1,798.39
-4.88%
1,890.60
-23.86%
2,482.97
Long Term Capital Lease Obligation
70.32
-21.40%
89.47
-59.78%
222.43
+3.23%
215.47
Non Current Deferred Liabilities
0.00
-100.00%
19.44
-53.34%
41.65
-31.53%
60.83
Non Current Deferred Taxes Liabilities
0.00
-100.00%
19.44
-53.34%
41.65
-31.53%
60.83
Other Non Current Liabilities
95.47
+31.59%
72.55
-40.82%
122.59
+6.65%
114.94
Stockholders Equity
-460.98
-178.62%
586.36
-36.55%
924.17
-2.27%
945.60
Common Stock Equity
-460.98
-178.62%
586.36
-36.55%
924.17
-2.27%
945.60
Capital Stock
152.78
-1.05%
154.40
+0.85%
153.09
+0.35%
152.56
Common Stock
152.78
-1.05%
154.40
+0.85%
153.09
+0.35%
152.56
Share Issued
76.39
-1.05%
77.20
+0.85%
76.55
+0.35%
76.28
Ordinary Shares Number
76.39
-1.05%
77.20
+0.85%
76.55
+0.35%
76.28
Additional Paid In Capital
466.88
+2.80%
454.15
+4.60%
434.19
+3.65%
418.89
Retained Earnings
-1,079.75
-4075.67%
27.16
-92.63%
368.71
-10.07%
410.01
Gains Losses Not Affecting Retained Earnings
-0.89
+98.21%
-49.34
-55.08%
-31.82
+11.26%
-35.85
Other Equity Adjustments
-0.89
+98.21%
-49.34
-55.08%
-31.82
+11.26%
-35.85
Total Equity Gross Minority Interest
-460.98
-178.62%
586.36
-36.55%
924.17
-2.27%
945.60
Total Capitalization
1,338.90
-43.86%
2,384.76
-15.28%
2,814.76
-17.90%
3,428.57
Working Capital
-399.20
-336.26%
168.97
-19.89%
210.91
-71.06%
728.72
Invested Capital
1,588.90
-34.55%
2,427.62
-19.66%
3,021.67
-12.33%
3,446.48
Total Debt
2,120.19
+9.81%
1,930.72
-16.78%
2,319.93
-14.59%
2,716.34
Net Debt
1,767.89
-2.53%
1,813.69
-2.20%
1,854.46
-23.73%
2,431.41
Capital Lease Obligations
70.32
-21.40%
89.47
-59.78%
222.43
+3.23%
215.47
Net Tangible Assets
-1,825.58
-114.31%
-851.83
+20.87%
-1,076.52
+5.25%
-1,136.14
Tangible Book Value
-1,825.58
-114.31%
-851.83
+20.87%
-1,076.52
+5.25%
-1,136.14
Inventories Adjustments Allowances
—
-64.96
+16.92%
-78.19
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-101.79
-163.03%
161.50
-78.20%
740.71
+127.91%
325.01
Cash Flow From Continuing Operating Activities
154.50
+7.52%
143.69
-57.29%
336.46
+3.52%
325.01
Cash From Discontinued Operating Activities
-256.29
-1539.08%
17.81
-95.59%
404.25
—
Net Income From Continuing Operations
-102.68
+70.72%
-350.74
-4038.63%
8.90
-60.23%
22.39
Depreciation Amortization Depletion
214.52
+18.34%
181.28
-13.83%
210.37
-8.00%
228.67
Depreciation And Amortization
214.52
+18.34%
181.28
-13.83%
210.37
-8.00%
228.67
Other Non Cash Items
9.73
+7.13%
9.09
-6.88%
9.76
-21.91%
12.49
Stock Based Compensation
12.87
-22.63%
16.64
+15.58%
14.39
-31.43%
20.99
Provisionand Write Offof Assets
—
—
-1.41
-142.65%
3.31
Asset Impairment Charge
0.00
-100.00%
307.11
0.00
0.00
Deferred Tax
-17.89
-122.42%
-8.04
-33.94%
-6.00
+77.22%
-26.36
Deferred Income Tax
-17.89
-122.42%
-8.04
-33.94%
-6.00
+77.22%
-26.36
Operating Gains Losses
-27.27
+20.38%
-34.25
+10.80%
-38.40
-46.23%
-26.26
Gain Loss On Sale Of PPE
-27.27
+22.86%
-35.35
-1.36%
-34.88
-32.83%
-26.26
Change In Working Capital
65.21
+188.53%
22.60
-83.56%
137.43
+47.65%
93.08
Change In Receivables
122.36
+3427.79%
-3.68
+59.10%
-8.99
-303.60%
4.42
Changes In Account Receivables
122.36
+3427.79%
-3.68
+59.10%
-8.99
-303.60%
4.42
Change In Inventory
-6.85
-49.29%
-4.59
+14.22%
-5.35
-103.21%
166.56
Change In Payables And Accrued Expense
6.48
-90.32%
66.89
+1175.39%
5.25
-61.58%
13.65
Change In Payable
6.48
-90.32%
66.89
+1175.39%
5.25
-61.58%
13.65
Change In Account Payable
6.48
-90.32%
66.89
+1175.39%
5.25
-61.58%
13.65
Change In Other Working Capital
-56.78
-57.61%
-36.03
-124.59%
146.53
+260.07%
-91.54
Investing Cash Flow
144.42
+223.93%
-116.53
+15.10%
-137.25
+92.39%
-1,804.48
Cash Flow From Continuing Investing Activities
198.99
+302.98%
-98.04
+9.14%
-107.89
+94.02%
-1,804.48
Cash From Discontinued Investing Activities
-54.57
-195.02%
-18.50
+37.00%
-29.36
—
Net PPE Purchase And Sale
-112.99
-12.58%
-100.36
+0.44%
-100.80
+8.12%
-109.71
Purchase Of PPE
-190.96
-12.14%
-170.29
+1.21%
-172.38
-9.04%
-158.09
Sale Of PPE
77.97
+11.50%
69.93
-2.30%
71.57
+47.93%
48.38
Capital Expenditure
-201.32
-10.22%
-182.66
-2.32%
-178.53
-7.17%
-166.58
Net Business Purchase And Sale
324.26
0.00
0.00
+100.00%
-1,684.61
Purchase Of Business
-18.09
0.00
0.00
+100.00%
-1,684.61
Gain Loss On Sale Of Business
—
—
—
0.00
Net Intangibles Purchase And Sale
-10.37
+16.24%
-12.38
-101.09%
-6.16
+27.51%
-8.49
Purchase Of Intangibles
-10.37
+16.24%
-12.38
-101.09%
-6.16
+27.51%
-8.49
Net Other Investing Changes
-1.91
-112.99%
14.70
+1670.83%
-0.94
+43.95%
-1.67
Financing Cash Flow
188.08
+170.28%
-267.60
+35.88%
-417.33
-127.88%
1,497.11
Cash Flow From Continuing Financing Activities
190.21
+176.08%
-250.02
+39.18%
-411.06
-127.46%
1,497.11
Net Issuance Payments Of Debt
203.50
+183.33%
-244.20
+41.40%
-416.69
-126.33%
1,582.50
Issuance Of Debt
2,914.78
+38.69%
2,101.60
+341.51%
476.00
-82.65%
2,743.30
Repayment Of Debt
-2,711.28
-15.58%
-2,345.80
-162.78%
-892.69
+23.10%
-1,160.80
Long Term Debt Issuance
2,914.78
+38.69%
2,101.60
+341.51%
476.00
-82.65%
2,743.30
Long Term Debt Payments
-2,711.28
-15.58%
-2,345.80
-162.78%
-892.69
+23.10%
-1,160.80
Net Long Term Debt Issuance
203.50
+183.33%
-244.20
+41.40%
-416.69
-126.33%
1,582.50
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
0.00
-100.00%
30.00
Net Common Stock Issuance
-10.18
0.00
0.00
0.00
Common Stock Payments
-10.18
0.00
0.00
—
Common Stock Dividend Paid
—
—
0.00
0.00
Cash Dividends Paid
—
—
0.00
0.00
Repurchase Of Capital Stock
-10.18
0.00
0.00
—
Proceeds From Stock Option Exercised
—
—
0.00
0.00
Net Other Financing Charges
-3.12
+46.52%
-5.83
-203.35%
5.64
+106.60%
-85.39
Changes In Cash
230.71
+203.62%
-222.64
-219.62%
186.13
+955.44%
17.64
Effect Of Exchange Rate Changes
1.90
+310.43%
-0.90
-246.98%
0.61
+117.59%
-3.48
Beginning Cash Position
49.38
-81.91%
272.92
+216.67%
86.19
+19.64%
72.03
End Cash Position
281.99
+471.04%
49.38
-81.91%
272.92
+216.67%
86.19
Free Cash Flow
-303.12
-1331.81%
-21.17
-103.77%
562.18
+254.86%
158.42
Interest Paid Supplemental Data
134.71
-4.83%
141.55
-7.63%
153.25
+43.19%
107.02
Income Tax Paid Supplemental Data
12.47
+124.58%
5.55
-11.62%
6.28
-81.51%
33.97
Common Stock Issuance
—
—
—
0.00
Interest Paid CFF
—
—
—
-42.60
Issuance Of Capital Stock
—
—
—
0.00
Sale Of Business
342.35
0.00
0.00
0.00
Cash From Discontinued Financing Activities
-2.13
+87.90%
-17.58
-180.20%
-6.27
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category